Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Country/Region, 2017, 2022 & 2028

2.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Segment by Type

2.2.1 Serotype 6B

2.2.2 7F Serotype

2.2.3 Serotype 9V

2.2.4 14 Serotype

2.2.5 Serotype 18C

2.2.6 Serotype 19A

2.2.7 19F Serotype

2.2.8 23F Serotype

2.2.9 24F Serotype

2.2.10 Other

2.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Type

2.3.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Type (2017-2022)

2.3.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue and Market Share by Type (2017-2022)

2.3.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sale Price by Type (2017-2022)

2.4 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Segment by Application

2.4.1 Infants from 6 Weeks to 15 Months Old

2.4.2 Children Aged 15 Months to 5 Years

2.5 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Application

2.5.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sale Market Share by Application (2017-2022)

2.5.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue and Market Share by Application (2017-2022)

2.5.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sale Price by Application (2017-2022)

3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Company

3.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Breakdown Data by Company

3.1.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Annual Sales by Company (2020-2022)

3.1.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Company (2020-2022)

3.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Annual Revenue by Company (2020-2022)

3.2.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Company (2020-2022)

3.2.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Company (2020-2022)

3.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sale Price by Company

3.4 Key Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Location Distribution

3.4.2 Players 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Geographic Region

4.1 World Historic 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size by Geographic Region (2017-2022)

4.1.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Annual Sales by Geographic Region (2017-2022)

4.1.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Annual Revenue by Geographic Region

4.2 World Historic 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size by Country/Region (2017-2022)

4.2.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Annual Sales by Country/Region (2017-2022)

4.2.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Annual Revenue by Country/Region

4.3 Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Growth

4.4 APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Growth

4.5 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Growth

4.6 Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Growth

5 Americas

5.1 Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country

5.1.1 Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country (2017-2022)

5.1.2 Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country (2017-2022)

5.2 Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Type

5.3 Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Region

6.1.1 APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Region (2017-2022)

6.1.2 APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Region (2017-2022)

6.2 APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Type

6.3 APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Country

7.1.1 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country (2017-2022)

7.1.2 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country (2017-2022)

7.2 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Type

7.3 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Country

8.1.1 Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country (2017-2022)

8.1.2 Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country (2017-2022)

8.2 Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Type

8.3 Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13)

10.3 Manufacturing Process Analysis of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13)

10.4 Industry Chain Structure of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13)

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Distributors

11.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Customer

12 World Forecast Review for 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Geographic Region

12.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size Forecast by Region

12.1.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Forecast by Region (2023-2028)

12.1.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Forecast by Type

12.7 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Forecast by Application

13 Key Players Analysis

13.1 Pfizer

13.1.1 Pfizer Company Information

13.1.2 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offered

13.1.3 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Pfizer Main Business Overview

13.1.5 Pfizer Latest Developments

13.2 Minhai Bio

13.2.1 Minhai Bio Company Information

13.2.2 Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offered

13.2.3 Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Minhai Bio Main Business Overview

13.2.5 Minhai Bio Latest Developments

13.3 Kexing Bio

13.3.1 Kexing Bio Company Information

13.3.2 Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offered

13.3.3 Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Kexing Bio Main Business Overview

13.3.5 Kexing Bio Latest Developments

13.4 Cansino Bio

13.4.1 Cansino Bio Company Information

13.4.2 Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offered

13.4.3 Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Cansino Bio Main Business Overview

13.4.5 Cansino Bio Latest Developments

13.5 Lanzhou Biological Preparations Institute

13.5.1 Lanzhou Biological Preparations Institute Company Information

13.5.2 Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offered

13.5.3 Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Lanzhou Biological Preparations Institute Main Business Overview

13.5.5 Lanzhou Biological Preparations Institute Latest Developments

14 Research Findings and Conclusion

Table 1. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Serotype 6B

Table 4. Major Players of 7F Serotype

Table 5. Major Players of Serotype 9V

Table 6. Major Players of 14 Serotype

Table 7. Major Players of Serotype 18C

Table 8. Major Players of Serotype 19A

Table 9. Major Players of 19F Serotype

Table 10. Major Players of 23F Serotype

Table 11. Major Players of 24F Serotype

Table 12. Major Players of Other

Table 13. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Type (2017-2022) & (K Units)

Table 14. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Type (2017-2022)

Table 15. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Type (2017-2022) & ($ million)

Table 16. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Type (2017-2022)

Table 17. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sale Price by Type (2017-2022) & (US$/Unit)

Table 18. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Application (2017-2022) & (K Units)

Table 19. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Application (2017-2022)

Table 20. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Application (2017-2022)

Table 21. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Application (2017-2022)

Table 22. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sale Price by Application (2017-2022) & (US$/Unit)

Table 23. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Company (2020-2022) & (K Units)

Table 24. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Company (2020-2022)

Table 25. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Company (2020-2022) ($ Millions)

Table 26. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Company (2020-2022)

Table 27. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sale Price by Company (2020-2022) & (US$/Unit)

Table 28. Key Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Producing Area Distribution and Sales Area

Table 29. Players 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Products Offered

Table 30. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 31. New Products and Potential Entrants

Table 32. Mergers & Acquisitions, Expansion

Table 33. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Geographic Region (2017-2022) & (K Units)

Table 34. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share Geographic Region (2017-2022)

Table 35. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Geographic Region (2017-2022) & ($ millions)

Table 36. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Geographic Region (2017-2022)

Table 37. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country/Region (2017-2022) & (K Units)

Table 38. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Country/Region (2017-2022)

Table 39. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country/Region (2017-2022) & ($ millions)

Table 40. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Country/Region (2017-2022)

Table 41. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country (2017-2022) & (K Units)

Table 42. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Country (2017-2022)

Table 43. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country (2017-2022) & ($ Millions)

Table 44. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Country (2017-2022)

Table 45. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Type (2017-2022) & (K Units)

Table 46. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Type (2017-2022)

Table 47. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Application (2017-2022) & (K Units)

Table 48. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Application (2017-2022)

Table 49. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Region (2017-2022) & (K Units)

Table 50. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Region (2017-2022)

Table 51. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Region (2017-2022) & ($ Millions)

Table 52. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Region (2017-2022)

Table 53. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Type (2017-2022) & (K Units)

Table 54. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Type (2017-2022)

Table 55. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Application (2017-2022) & (K Units)

Table 56. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Application (2017-2022)

Table 57. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country (2017-2022) & (K Units)

Table 58. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Country (2017-2022)

Table 59. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country (2017-2022) & ($ Millions)

Table 60. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Country (2017-2022)

Table 61. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Type (2017-2022) & (K Units)

Table 62. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Type (2017-2022)

Table 63. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Application (2017-2022) & (K Units)

Table 64. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Application (2017-2022)

Table 65. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country (2017-2022) & (K Units)

Table 66. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Country (2017-2022)

Table 67. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country (2017-2022) & ($ Millions)

Table 68. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Country (2017-2022)

Table 69. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Type (2017-2022) & (K Units)

Table 70. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Type (2017-2022)

Table 71. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Application (2017-2022) & (K Units)

Table 72. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Application (2017-2022)

Table 73. Key Market Drivers & Growth Opportunities of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13)

Table 74. Key Market Challenges & Risks of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13)

Table 75. Key Industry Trends of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13)

Table 76. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Raw Material

Table 77. Key Suppliers of Raw Materials

Table 78. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Distributors List

Table 79. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Customer List

Table 80. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Forecast by Region (2023-2028) & (K Units)

Table 81. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Forecast by Region

Table 82. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share Forecast by Region (2023-2028)

Table 84. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Forecast by Region (2023-2028) & (K Units)

Table 87. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 88. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Forecast by Country (2023-2028) & (K Units)

Table 89. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 90. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Forecast by Country (2023-2028) & (K Units)

Table 91. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 92. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Forecast by Type (2023-2028) & (K Units)

Table 93. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share Forecast by Type (2023-2028)

Table 94. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 95. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share Forecast by Type (2023-2028)

Table 96. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Forecast by Application (2023-2028) & (K Units)

Table 97. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share Forecast by Application (2023-2028)

Table 98. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 99. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share Forecast by Application (2023-2028)

Table 100. Pfizer Basic Information, 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturing Base, Sales Area and Its Competitors

Table 101. Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offered

Table 102. Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 103. Pfizer Main Business

Table 104. Pfizer Latest Developments

Table 105. Minhai Bio Basic Information, 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturing Base, Sales Area and Its Competitors

Table 106. Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offered

Table 107. Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 108. Minhai Bio Main Business

Table 109. Minhai Bio Latest Developments

Table 110. Kexing Bio Basic Information, 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturing Base, Sales Area and Its Competitors

Table 111. Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offered

Table 112. Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 113. Kexing Bio Main Business

Table 114. Kexing Bio Latest Developments

Table 115. Cansino Bio Basic Information, 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturing Base, Sales Area and Its Competitors

Table 116. Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offered

Table 117. Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 118. Cansino Bio Main Business

Table 119. Cansino Bio Latest Developments

Table 120. Lanzhou Biological Preparations Institute Basic Information, 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturing Base, Sales Area and Its Competitors

Table 121. Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offered

Table 122. Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 123. Lanzhou Biological Preparations Institute Main Business

Table 124. Lanzhou Biological Preparations Institute Latest Developments

List of Figures

Figure 1. Picture of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13)

Figure 2. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Serotype 6B

Figure 10. Product Picture of 7F Serotype

Figure 11. Product Picture of Serotype 9V

Figure 12. Product Picture of 14 Serotype

Figure 13. Product Picture of Serotype 18C

Figure 14. Product Picture of Serotype 19A

Figure 15. Product Picture of 19F Serotype

Figure 16. Product Picture of 23F Serotype

Figure 17. Product Picture of 24F Serotype

Figure 18. Product Picture of Other

Figure 19. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Type in 2021

Figure 20. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Type (2017-2022)

Figure 21. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumed in Infants from 6 Weeks to 15 Months Old

Figure 22. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market: Infants from 6 Weeks to 15 Months Old (2017-2022) & (K Units)

Figure 23. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumed in Children Aged 15 Months to 5 Years

Figure 24. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market: Children Aged 15 Months to 5 Years (2017-2022) & (K Units)

Figure 25. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Application (2017-2022)

Figure 26. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Application in 2021

Figure 27. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market by Company in 2021 ($ Million)

Figure 28. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Company in 2021

Figure 29. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Geographic Region (2017-2022)

Figure 30. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Geographic Region in 2021

Figure 31. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Region (2017-2022)

Figure 32. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Country/Region in 2021

Figure 33. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales 2017-2022 (K Units)

Figure 34. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue 2017-2022 ($ Millions)

Figure 35. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales 2017-2022 (K Units)

Figure 36. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue 2017-2022 ($ Millions)

Figure 37. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales 2017-2022 (K Units)

Figure 38. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue 2017-2022 ($ Millions)

Figure 39. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales 2017-2022 (K Units)

Figure 40. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue 2017-2022 ($ Millions)

Figure 41. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Country in 2021

Figure 42. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Country in 2021

Figure 43. United States 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2017-2022 ($ Millions)

Figure 44. Canada 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2017-2022 ($ Millions)

Figure 45. Mexico 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2017-2022 ($ Millions)

Figure 46. Brazil 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2017-2022 ($ Millions)

Figure 47. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Region in 2021

Figure 48. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Regions in 2021

Figure 49. China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2017-2022 ($ Millions)

Figure 50. Japan 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2017-2022 ($ Millions)

Figure 51. South Korea 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2017-2022 ($ Millions)

Figure 52. Southeast Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2017-2022 ($ Millions)

Figure 53. India 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2017-2022 ($ Millions)

Figure 54. Australia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2017-2022 ($ Millions)

Figure 55. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Country in 2021

Figure 56. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Country in 2021

Figure 57. Germany 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2017-2022 ($ Millions)

Figure 58. France 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2017-2022 ($ Millions)

Figure 59. UK 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2017-2022 ($ Millions)

Figure 60. Italy 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2017-2022 ($ Millions)

Figure 61. Russia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2017-2022 ($ Millions)

Figure 62. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Country in 2021

Figure 63. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Country in 2021

Figure 64. Egypt 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2017-2022 ($ Millions)

Figure 65. South Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2017-2022 ($ Millions)

Figure 66. Israel 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2017-2022 ($ Millions)

Figure 67. Turkey 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2017-2022 ($ Millions)

Figure 68. GCC Country 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2017-2022 ($ Millions)

Figure 69. Manufacturing Cost Structure Analysis of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) in 2021

Figure 70. Manufacturing Process Analysis of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13)

Figure 71. Industry Chain Structure of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13)

Figure 72. Channels of Distribution

Figure 73. Distributors Profiles